| Stage | MCD | % of rev | CBRL | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $7.1B | 100.00% | $849M | 100.00% | MCD ×8.36 |
| Gross profit | $4.3B | 60.30% | $516M | 60.73% | CBRL +0.4pp |
| Operating income | $3.3B | 47.02% | $40M | 4.73% | MCD +42.3pp |
| Pre-tax income | $2.9B | 41.36% | $10M | 1.20% | MCD +40.2pp |
| Net income | $2.4B | 33.27% | $12M | 1.44% | MCD +31.8pp |
| Stage | MCD | CBRL | Gap · A − B |
|---|---|---|---|
| Revenue | $7.1B100.00% | $849M100.00% | MCD ×8.36 |
| Gross profit | 60.30%$4.3B | 60.73%$516M | CBRL +0.4pp |
| Operating income | 47.02%$3.3B | 4.73%$40M | MCD +42.3pp |
| Pre-tax income | 41.36%$2.9B | 1.20%$10M | MCD +40.2pp |
| Net income |
| 33.27%$2.4B |
| 1.44%$12M |
| MCD +31.8pp |
No shared counterparties.